Roche Diagnostics: Advancing Healthcare in Asia through Personalized Care & Diagnostic Excellence

Roche Diagnostics is a division of Roche. The organization develops and integrates diagnostic solutions that address the challenges of today and anticipate the needs of tomorrow. In more than 100 countries, Roche Diagnostics offers the industry’s most comprehensive in vitro diagnostics solutions, covering molecular diagnostics, clinical chemistry and immunoassays, tissue diagnostics, point of care testing, patient self-testing, next-generation sequencing, laboratory and decision support solutions.

In an engaging conversation with #biztechasia Lance Little, Head of Region at Roche Diagnostics Asia Pacific, delved into the intricacies of diagnostics, emphasizing its pivotal role in enhancing patient experiences and outcomes. He emphasized that diagnostics form the foundation of healthcare, harnessing advanced technology to significantly improve treatment results and early diagnosis, in particular, plays a vital role in achieving optimal outcomes.

Furthermore, Lance urged individuals to reimagine their approach to health, likening it to managing a bank account. Recognizing the significance of diagnostics, he emphasizes the responsibility for each individual to shift their mindset from an illness to wellness paradigm.

In addition, Lance discussed:

Insights into Roche’s position as a leader in innovation, enabling personalized healthcare and targeted therapies for patients.
Critical healthcare challenges in the Asia Pacific region and Roche’s role in addressing these challenges. He highlighted issues related to health inequity, particularly women’s health from a societal perspective, and the importance of improving access to healthcare.
How Roche is collaborating with governments to facilitate healthcare screenings, providing examples of the company’s collaboration with the government of Pakistan, where they worked together to equip key laboratories across the country with the latest molecular technology for diagnosing hepatitis C.
Roche’s role in advocating for long-term approaches among policymakers to ensure a happy and healthy population.